GENELUX Corp
GNLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001231457
In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding GENELUX Corp changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 78 | 2 | 71 | −5 |
| Shares | 9.12M | 1.77M | 9.30M | +1.95M (+26.5%) |
| Value | $39.6M | $7.71M | $23.3M | −$8.58M (−26.9%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held GENELUX Corp at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 1,695,480 | $4.10M | 0.00% |
| Vanguard Fiduciary Trust Co | 251,610 | $608.9K | 0.00% |
| CM Management, LLC | 250,000 | $605.0K | 0.51% |
| Mariner, LLC | 27,866 | $67.4K | 0.00% |
| Catalyst Funds Management Pty Ltd | 21,824 | $52.8K | 0.01% |
| Nine Masts Capital Ltd | 17,473 | $42.3K | 0.01% |
| Vanguard Global Advisers, LLC | 16,010 | $38.7K | 0.00% |
| HRT Financial LP | 13,447 | $32.0K | 0.00% |
| Diametric Capital, LP | 12,150 | $29.4K | 0.01% |
| Cassaday & Co Wealth Management LLC | 2,553 | $6.18K | 0.00% |
| Mather Group, LLC. | 1,190 | $2.88K | 0.00% |
| Caitong International Asset Management Co., Ltd | 3 | $7 | 0.00% |
Sold out (17)
Institutions that held GENELUX Corp at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Alyeska Investment Group, L.P. | 285,000 | $1.24M |
| Marshall Wace, LLP | 139,148 | $606.7K |
| Millennium Management LLC | 104,399 | $455.2K |
| Qube Research & Technologies Ltd | 92,795 | $404.6K |
| Jane Street Group, LLC | 71,741 | $312.8K |
| ExodusPoint Capital Management, LP | 54,633 | $238.2K |
| Point72 Asset Management, L.P. | 39,560 | $172.5K |
| Lighthouse Investment Partners, LLC | 22,560 | $98.4K |
| Balyasny Asset Management LLC | 21,465 | $93.6K |
| Citadel Advisors LLC | 19,415 | $84.6K |
| Citigroup Inc | 14,945 | $65.2K |
| Squarepoint Ops LLC | 11,866 | $51.7K |
| Jefferies Financial Group Inc. | 10,940 | $47.7K |
| Tower Research Capital LLC (TRC) | 3,885 | $16.9K |
| SageView Advisory Group, LLC | 1,264 | $5.51K |
| Group One Trading, L.P. | 655 | $2.86K |
| EverSource Wealth Advisors, LLC | 150 | $654 |
Not filed for Q1 2026 yet (2)
Institutions that held GENELUX Corp at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,551,449 | $6.76M |
| Global Retirement Partners, LLC | 217,092 | $946.5K |